(Y60.1) During infusion or transfusion

More details coming soon

Icon
232 877 in individuals diagnosis during infusion or transfusion confirmed
Icon
9 629 deaths with diagnosis during infusion or transfusion
Icon
4% mortality rate associated with the disease during infusion or transfusion

Diagnosis during infusion or transfusion is diagnosed Women are 19.45% more likely than Men

93 793

Men receive the diagnosis during infusion or transfusion

4 812 (5.1 %)

Died from this diagnosis.

100
95
90
85
80
75
70
65
60
55
50
45
40
35
30
25
20
15
10
5
0
139 084

Women receive the diagnosis during infusion or transfusion

4 817 (3.5 %)

Died from this diagnosis.

Risk Group for the Disease during infusion or transfusion - Men aged 65-69 and Women aged 75-79

Icon
In Men diagnosis is most often set at age 0-9, 15-94
Icon
Less common in men the disease occurs at Age 10-14, 95+Less common in women the disease occurs at Age 0-5, 10-14, 95+
Icon
In Women diagnosis is most often set at age 5-9, 15-94

Disease Features during infusion or transfusion

Icon
Absence or low individual and public risk
Icon

During infusion or transfusion - what does this mean

A transfusion or infusion reaction occurs when a person's body has an adverse reaction to the foreign blood or fluids that are being administered. this reaction can be caused by a mismatched blood type, an infection in the donor blood, or an allergic reaction to the fluids or medications being infused or transfused. symptoms of a reaction can include fever, chills, hives, rash, low blood pressure, and difficulty breathing.

What happens during the disease - during infusion or transfusion

The pathogenesis of transfusion reactions is thought to be due to the introduction of foreign antigens from the donor's blood into the recipient's body. this can lead to the formation of antibodies and an immune response, which can range from mild to severe. in some cases, the recipient's body may also be unable to process the transfused blood correctly, leading to a range of clinical symptoms such as fever, chills, rash, and nausea. in rare cases, severe reactions can occur, leading to anaphylaxis and even death.

Clinical Pattern

More details coming soon

How does a doctor diagnose

  • Check for any signs of infection.
  • Check the patient's vital signs, including temperature, pulse, and blood pressure.
  • Perform a physical examination to assess the patient's overall health.
  • Take a detailed medical history.
  • Order laboratory tests, such as a complete blood count and a chemistry panel.
  • Order imaging tests, such as X-rays, CT scans, and MRI scans.
  • Perform a biopsy to obtain a sample of tissue for examination.
  • Perform endoscopy to examine the gastrointestinal tract.
  • Perform genetic testing to identify any genetic abnormalities.

Treatment and Medical Assistance

Main Goal: Treating the Disease
  • Administering the infusion or transfusion
  • Monitoring the patient's vitals
  • Checking for any adverse reactions
  • Adjusting the rate of infusion or transfusion as needed
  • Ensuring the patient is comfortable
  • Educating the patient about the treatment
  • Checking for any signs of infection
  • Providing emotional support to the patient
  • Providing follow-up care
Icon
16 Days of Hospitalization Required
Icon
Average Time for Outpatient Care Not Established

During infusion or transfusion - Prevention

In order to prevent infections during infusion or transfusion, it is important to ensure that all equipment and supplies are sterile and that proper infection control procedures are followed. additionally, it is important to screen donors for infections and to ensure that any blood or blood products that are used are from a reputable source.

Specified forms of the disease

(O31.0) Papyraceous fetus
(O31.1) Continuing pregnancy after abortion of one fetus or more
(O31.2) Continuing pregnancy after intrauterine death of one fetus or more
(O31.8) Other complications specific to multiple gestation